Skip to main content

Immuneering Corp

IMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001790340

No open-market purchases or sales by Immuneering Corp insiders were filed in the last 90 days; 111 institutions reported holding it in 13F filings for Q2 2026, worth $171.6M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Immuneering Corp changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of IMRX: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders3539+4
Shares4.50M3.83M−668.9K (−14.9%)
Value$6.84M$12.9M+$6.07M (+88.8%)

New holders (11)

Institutions that held Immuneering Corp at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to IMRX in Q2 2025
InstitutionSharesValue% of portfolio
FMR LLC221,000$744.8K0.00%
CI Private Wealth, LLC63,740$214.8K0.00%
Flower City Capital32,029$107.9K0.06%
Cubist Systematic Strategies, LLC29,404$99.1K0.00%
XTX Topco Ltd26,829$90.4K0.00%
Alethea Capital Management, LLC22,935$77.3K0.06%
Renaissance Technologies LLC18,200$61.3K0.00%
Kingsview Wealth Management, LLC14,000$47.2K0.00%
Wells Fargo & Company10,000$33.7K0.00%
Advisor Group Holdings, Inc.4,300$14.5K0.00%
Point72 (DIFC) Ltd16$540.00%

Sold out (7)

Institutions that held Immuneering Corp at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of IMRX in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Price T Rowe Associates Inc659,009$1.00M
Manufacturers Life Insurance Company, The82,667$125.7K
TD Asset Management Inc71,066$108.0K
Jane Street Group, LLC20,869$31.7K
Engineers Gate Manager LP10,607$16.1K
Federated Hermes, Inc.3,954$6.01K
US Bancorp228$347